Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 245

1.

A Genetic Variant of the Sortilin 1 Gene is Associated with Reduced Risk of Alzheimer's Disease.

Andersson CH, Hansson O, Minthon L, Andreasen N, Blennow K, Zetterberg H, Skoog I, Wallin A, Nilsson S, Kettunen P.

J Alzheimers Dis. 2016 Jul 1. [Epub ahead of print]

PMID:
27392867
2.

Reliability, validity and clinical correlates of the Quality of Life in Alzheimer's disease (QoL-AD) scale in medical inpatients.

Torisson G, Stavenow L, Minthon L, Londos E.

Health Qual Life Outcomes. 2016 Jun 14;14:90. doi: 10.1186/s12955-016-0493-8.

3.

Longitudinal cerebrospinal fluid biomarker measurements in preclinical sporadic Alzheimer's disease: A prospective 9-year study.

Stomrud E, Minthon L, Zetterberg H, Blennow K, Hansson O.

Alzheimers Dement (Amst). 2015 Oct 9;1(4):403-11. doi: 10.1016/j.dadm.2015.09.002. eCollection 2015 Dec.

4.

Prevalence of Dementia With Lewy Body Symptoms: A Cross-Sectional Study in 40 Swedish Nursing Homes.

Zahirovic I, Wattmo C, Torisson G, Minthon L, Londos E.

J Am Med Dir Assoc. 2016 May 7. pii: S1525-8610(16)30057-3. doi: 10.1016/j.jamda.2016.03.017. [Epub ahead of print]

5.

Myo-inositol changes precede amyloid pathology and relate to APOE genotype in Alzheimer disease.

Voevodskaya O, Sundgren PC, Strandberg O, Zetterberg H, Minthon L, Blennow K, Wahlund LO, Westman E, Hansson O; Swedish BioFINDER study group.

Neurology. 2016 May 10;86(19):1754-61. doi: 10.1212/WNL.0000000000002672. Epub 2016 Apr 15.

6.

Cerebrospinal fluid soluble TREM2 in aging and Alzheimer's disease.

Henjum K, Almdahl IS, Årskog V, Minthon L, Hansson O, Fladby T, Nilsson LN.

Alzheimers Res Ther. 2016 Apr 27;8(1):17. doi: 10.1186/s13195-016-0182-1.

7.

Copeptin, a Marker of Vasopressin, Predicts Vascular Dementia but not Alzheimer's Disease.

Nilsson ED, Melander O, Elmståhl S, Lethagen E, Minthon L, Pihlsgård M, Nägga K.

J Alzheimers Dis. 2016 Apr 12;52(3):1047-53. doi: 10.3233/JAD-151118.

PMID:
27079711
8.

CSF Aβ42/Aβ40 and Aβ42/Aβ38 ratios: better diagnostic markers of Alzheimer disease.

Janelidze S, Zetterberg H, Mattsson N, Palmqvist S, Vanderstichele H, Lindberg O, van Westen D, Stomrud E, Minthon L, Blennow K; Swedish BioFINDER study group, Hansson O.

Ann Clin Transl Neurol. 2016 Jan 1;3(3):154-65. doi: 10.1002/acn3.274. eCollection 2016 Mar.

9.

Increased amyloidogenic APP processing in APOE ɛ4-negative individuals with cerebral β-amyloidosis.

Mattsson N, Insel PS, Palmqvist S, Stomrud E, van Westen D, Minthon L, Zetterberg H, Blennow K, Hansson O.

Nat Commun. 2016 Mar 7;7:10918. doi: 10.1038/ncomms10918.

10.

Mild versus moderate stages of Alzheimer's disease: three-year outcomes in a routine clinical setting of cholinesterase inhibitor therapy.

Wattmo C, Minthon L, Wallin ÅK.

Alzheimers Res Ther. 2016 Feb 17;8:7. doi: 10.1186/s13195-016-0174-1.

11.

Cerebral white matter lesions - associations with Aβ isoforms and amyloid PET.

van Westen D, Lindqvist D, Blennow K, Minthon L, Nägga K, Stomrud E, Zetterberg H, Hansson O.

Sci Rep. 2016 Feb 9;6:20709. doi: 10.1038/srep20709.

12.

Cerebrospinal fluid levels of IL-6 are decreased and correlate with cognitive status in DLB patients.

Wennström M, Hall S, Nägga K, Londos E, Minthon L, Hansson O.

Alzheimers Res Ther. 2015 Oct 5;7(1):63. doi: 10.1186/s13195-015-0145-y.

13.

Performance and complications of lumbar puncture in memory clinics: Results of the multicenter lumbar puncture feasibility study.

Duits FH, Martinez-Lage P, Paquet C, Engelborghs S, Lleó A, Hausner L, Molinuevo JL, Stomrud E, Farotti L, Ramakers IH, Tsolaki M, Skarsgård C, Åstrand R, Wallin A, Vyhnalek M, Holmber-Clausen M, Forlenza OV, Ghezzi L, Ingelsson M, Hoff EI, Roks G, de Mendonça A, Papma JM, Izagirre A, Taga M, Struyfs H, Alcolea DA, Frölich L, Balasa M, Minthon L, Twisk JW, Persson S, Zetterberg H, van der Flier WM, Teunissen CE, Scheltens P, Blennow K.

Alzheimers Dement. 2016 Feb;12(2):154-63. doi: 10.1016/j.jalz.2015.08.003. Epub 2015 Sep 11.

PMID:
26368321
14.

Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease.

Palmqvist S, Zetterberg H, Mattsson N, Johansson P; Alzheimer's Disease Neuroimaging Initiative, Minthon L, Blennow K, Olsson M, Hansson O; Swedish BioFINDER Study Group.

Neurology. 2015 Oct 6;85(14):1240-9. doi: 10.1212/WNL.0000000000001991. Epub 2015 Sep 9.

15.

Longitudinal Associations between Survival in Alzheimer's Disease and Cholinesterase Inhibitor Use, Progression, and Community-Based Services.

Wattmo C, Londos E, Minthon L.

Dement Geriatr Cogn Disord. 2015;40(5-6):297-310. doi: 10.1159/000437050. Epub 2015 Sep 4.

16.

The Inflammatory Marker YKL-40 Is Elevated in Cerebrospinal Fluid from Patients with Alzheimer's but Not Parkinson's Disease or Dementia with Lewy Bodies.

Wennström M, Surova Y, Hall S, Nilsson C, Minthon L, Hansson O, Nielsen HM.

PLoS One. 2015 Aug 13;10(8):e0135458. doi: 10.1371/journal.pone.0135458. eCollection 2015.

17.

Characterization of the postsynaptic protein neurogranin in paired cerebrospinal fluid and plasma samples from Alzheimer's disease patients and healthy controls.

Kvartsberg H, Portelius E, Andreasson U, Brinkmalm G, Hellwig K, Lelental N, Kornhuber J, Hansson O, Minthon L, Spitzer P, Maler JM, Zetterberg H, Blennow K, Lewczuk P.

Alzheimers Res Ther. 2015 Jul 1;7(1):40. doi: 10.1186/s13195-015-0124-3. eCollection 2015.

18.

Cerebral Microbleeds and White Matter Hyperintensities in Cognitively Healthy Elderly: A Cross-Sectional Cohort Study Evaluating the Effect of Arterial Stiffness.

Gustavsson AM, Stomrud E, Abul-Kasim K, Minthon L, Nilsson PM, Hansson O, Nägga K.

Cerebrovasc Dis Extra. 2015 May 20;5(2):41-51. doi: 10.1159/000377710. eCollection 2015 May-Aug.

19.

Medial temporal lobe atrophy is underreported and may have important clinical correlates in medical inpatients.

Torisson G, van Westen D, Stavenow L, Minthon L, Londos E.

BMC Geriatr. 2015 Jun 16;15:65. doi: 10.1186/s12877-015-0066-4.

20.

Associations of central and brachial blood pressure with cognitive function: a population-based study.

Nilsson ED, Elmståhl S, Minthon L, Nilsson PM, Pihlsgård M, Nägga K.

J Hum Hypertens. 2016 Feb;30(2):95-9. doi: 10.1038/jhh.2015.33. Epub 2015 Apr 16.

PMID:
25880593
Items per page

Supplemental Content

Loading ...
Write to the Help Desk